-
Mapping Anatomic Pathology Laboratories of Public Hospitals in Greece: Units, Infrastructure, Personnel, and Workload Estimation
Sep 9, 2025, 16:22 PM -
Evidence-Driven Simulated Agents to Train Reinforcement Learning for Personalization in mHealth Interventions
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
The Fiscal Case for Investing in COVID-19 Vaccination: A UK Treasury Perspective
Sep 9, 2025, 16:22 PM -
Evaluation of the Effectiveness of a Naturalness Probe for Assessing Human- and Nonhuman-Generated COA Translations in Linguistic Validation Cognitive Debriefing Interviews
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of GAAD Algorithm for Hepatocellular Carcinoma Surveillance of Cirrhotic Patients Using Italian Real-World Data
Sep 9, 2025, 16:22 PM -
Development of a Preliminary Conceptual Model to Capture the Adult Patient Experience of Follicular Lymphoma
Sep 9, 2025, 16:22 PM -
Clinical and Economic Impact of Early Treatment in Relapsing Remitting Multiple Sclerosis With High-Efficacy Disease-Modifying Therapy in Mexico
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis Of Erdosteine for the Prevention of Exacerbations in Patients With COPD in the Czech Republic
Sep 9, 2025, 16:22 PM -
Applying G-methods to Account for Treatment Switching in Postmarketing Effectiveness Evaluation: A Case Study of GLP-1 Receptor Agonists for Diabetic Kidney Disease
Sep 9, 2025, 16:22 PM -
NICE Guidance, Not-So-NICE Realities: Resource Constraints in HTA
Sep 9, 2025, 16:22 PM -
Graphical Evidence Frameworks to Visualize the Holistic Value of Healthcare Interventions
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Quizartinib for Adult Patients With Newly Diagnosed FLT3-ITD+ Acute Myeloid Leukemia (AML) in Spain
Sep 9, 2025, 16:22 PM -
Cost-Savings Assessment of Fitusiran Prophylaxis in Minimizing Breakthrough Bleeding Treatment Expenses in the United Arab Emirates
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Ulcerative Colitis Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile
Sep 9, 2025, 16:22 PM -
Bootstrap Methods for Confidence Interval Estimation in Small Samples: Implications for Health Economics
Sep 9, 2025, 16:22 PM -
Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database
Sep 9, 2025, 16:22 PM -
Bayesian Network Meta-Analysis of Weight Loss Efficacy for GLP-1 Receptor Agonists and Tirzepatide
Sep 9, 2025, 16:22 PM -
Indirect Costs Associated With Pneumococcal Disease: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM
